Cervical cancer is one of the most common cancers threatening women's health, and the
persistent infection of high-risk human papillomavirus (HPV) is closely related to the …

Oncogenic human papillomavirus (HPV) is a common genital infection that has the potential
to develop into cervical cancer in some women. This Review summarises current knowledge …

Human papilloma virus (HPV)-induced cervical cancer constitutively expresses viral E6/E7
oncoproteins and is an excellent target for T cell-based immunotherapy. However, not all …

Background: Vulval intraepithelial neoplasia (VIN) is a premalignant condition, which is
frequently associated with type HPV16 infection, and multifocal disease has high rates of …

Highlights•Current prophylactic vaccines protect only against infection with high risk types
HPV16 and 18.•Several new platform technologies are being applied to the development of …

The development of human papillomavirus (HPV) vaccines has made substantive progress,
as represented by the approval of five prophylactic vaccines since 2006. Generally, the …

High prevalence and mortality rates of cervical cancer create an imperative need to clarify
the uniqueness of HPV (Human Papillomavirus) infection, which serves as the key causative …

Persistent infection with human papillomavirus (HPV) type 16 is a major risk factor for the
development of head and neck squamous cell carcinoma (HNSCC), in particular …

Carcinomas of the anogenital tract, in particular cervical cancer, remains one of the most
common cancers in women, and represent the most frequent gynecological malignancies …

The duration over which antibody responses persist following HPV vaccination is unknown.
To estimate the longevity of responses induced by HPV-16 vaccination, two models were …